The Worldwide Radiation Dose Management Industry is Expected to Reach $586.7 Million by 2032 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Radiation Dose Management Market - A Global and Regional Analysis: Focus on Product, Modality, Mode of Deployment, End User, and Country Analysis - Analysis and Forecast, 2022-2032" report has been added to ResearchAndMarkets.com's offering.

The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032.

The growth in the global radiation dose management market is expected to be driven by the rising prevalence of chronic disorders requiring diagnostic intervention, the growing focus on interventional radiology (IR), and the growing awareness surrounding patient safety and the harmful and biological effects of overexposure to ionizing radiation.

Impact of COVID-19

The decline in imaging volumes during the COVID-19 pandemic impacted the utilization of radiation diagnostic equipment. All radiology equipment had to be thoroughly disinfected using ethanol owing to the strict protocols to minimize the risk of transmission of COVID-19.

In the post-COVID-19 scenario, imaging volumes are expected to return gradually to pre-pandemic levels. As the severity of the COVID-19 pandemic declines, hospitals are expected to reallocate resources toward radiology and pursue diagnostic imaging with renewed vigor.

Moreover, in the long term, radiology practices could be permanently redesigned as radiologists become more comfortable treating patients remotely. Furthermore, hospitals and other healthcare institutions are expected to be better equipped to deal with unprecedented events that may disrupt their businesses.

The COVID-19 pandemic placed high importance on automating tasks requiring manual intervention. While conventionally, data transfer and dose recording were done manually, the advent of advanced dose management software (DMS) has enabled automated data transfer from imaging systems into the DMS as well as automated dose recording.

This helps eliminate human error and reduces the need for human intervention, which was a concept that gained momentum as a result of the COVID-19 pandemic.

Market Dynamics

Drivers

• Increasing installed bases of radiology equipment and the number of scans lead to a higher risk of radiation exposure, thus creating demand for dose management solutions.
• Increasing concern related to radiation overexposure is leading to higher adoption of dose management solutions.
• Growing awareness and initiatives for radiation dose management are expected to push the adoption of dose management software.
• Advancements in dose optimization and benchmarking in various countries will encourage healthcare institutions to adopt dose management software.
• Increasing prevalence of cardiovascular diseases and growing occupational hazards in Cath labs lead to growing concern surrounding the effects of radiation exposure.
• Growing focus on interventional radiology (IR) is expected to increase demand for IR imaging systems and subsequently lead to a higher risk of radiation exposure.

Restraints

• The lack of awareness among the population and the shortage of skilled and trained professionals leading to a steep learning curve hinders the adoption of dose management software.
• The lack of diagnostic reference levels (DRLs) for radiation dose benchmarking in low-income countries causes healthcare institutions to not pursue the adoption of dose management software with vigor.

Opportunities

• Cloud-based solutions enable easy access and secure sharing of radiation dose data.
• Growing initiatives on radiation dose management for pediatric procedures will enable the development of software solutions catering to dose management in the pediatric population.

Market Segmentation

Segmentation 1: by Modality

• CT Scanners
• X-Ray, CR, and DR
• Mammography Systems
• Interventional Angiography Systems/Angio CT
• Fluoroscopy Systems
• PET Scanners and SPECT
• Hybrid Imaging

The global radiation dose management market (by modality) was dominated by the CT scanners segment in 2021, and the trend is expected to continue till the end of the forecast period 2022-2032.

Segmentation 2: by Product

• Radimetrics Enterprise Platform
• DoseWatch and DoseWatch Explore
• teamplay Dose
• NEXO [DOSE]
• tqm/Dose and DoseMonitor
• Radiation Dose Monitor
• Imalogix Platform
• Syncro-Dose
• NovaDose
• DoseWise Portal
• SafeCT
• MyXrayDose
• DoseM
• Dose Tracking System
• DoseTrack

The global radiation dose management market (by product) is dominated by the Radimetrics Enterprise Platform, followed by DoseWatch.

Segmentation 3: by Mode of Deployment

• Web-Based
• On-Premise
• Cloud-Based

The global radiation dose management market (by mode of deployment) is dominated by the web-based segment.

Segmentation 4: by End User

• Hospitals
• Diagnostic Centers
• Others

The global radiation dose management market (by end user) is dominated by the hospitals segment.

Segmentation 5: by Region

• North America - U.S. and Canada
• Europe - Germany, France, U.K., Italy, Spain, Netherlands, and Rest-of-Europe
• Asia-Pacific - Japan, China, India, Australia and New Zealand, South Korea, and Rest-of-Asia-Pacific
• Latin America - Brazil, Mexico, and Rest-of-Latin America
• Middle East and Africa

North America held the largest share of 43.71% in 2022, followed by Europe at 24.45%. Additionally, Asia-Pacific is anticipated to grow considerably at high growth, registering a CAGR of 11.83%, respectively, during the forecast period 2022-2032.

Companies Mentioned

• Agfa-Gevaert Group
• Bracco
• Bayer AG
• Canon Inc.
• FUJIFILM Holdings Corporation
• Guerbet
• General Electric Company
• Imalogix
• Infinitt Healthcare Co., Ltd.
• Koninklijke Philips N.V.
• LANDAUER
• Medic Vision Imaging Solutions Ltd.
• Medsquare
• MyXrayDose Ltd.
• Novarad Corporation
• PACSHealth, LLC
• Qaelum NV
• Sectra AB
• SST Group Inc.
• Siemens Healthineers AG
• Virtual Phantoms Inc.

For more information about this report visit https://www.researchandmarkets.com/r/k7g8p2